| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/08/2000 | CA2366852A1 Transdermal device comprising non-steroidal anti-inflammatory drugs incorporated in acrylic adhesive polymer matrix |
| 09/08/2000 | CA2366755A1 Method of increasing bone volume using non-naturally-occurring ep, selective agonists |
| 09/08/2000 | CA2366318A1 Novel pharmaceutical, dietary and cosmetic compositions comprising zinger officinale roscoe, eicosapentaenoic acid and/or docosahexaenoic acid |
| 09/08/2000 | CA2366073A1 Use of succinic acid or salts thereof and method of treating insulin resistance |
| 09/08/2000 | CA2366041A1 Method for treating exercise induced asthma |
| 09/08/2000 | CA2366038A1 Treating a variety of pathological conditions, including spasticity and convulsions, by effecting modulation of cns activity with isovaleramide, isovaleric acid, or a related compound |
| 09/08/2000 | CA2366036A1 Method for treating copd |
| 09/08/2000 | CA2365391A1 Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists |
| 09/08/2000 | CA2365326A1 Methods of increasing bone volume using non-naturally-occurring fp selective agonists and antiresorptive compounds |
| 09/08/2000 | CA2365290A1 Use of ceramides for the treatment of cystic fibrosis |
| 09/08/2000 | CA2365032A1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy |
| 09/08/2000 | CA2364911A1 N-substituted indolines as estrogenic agents |
| 09/08/2000 | CA2364878A1 Alkenyl- and alkynyl-containing metalloprotease inhibitors |
| 09/08/2000 | CA2364592A1 Genetic and epigenetic manipulation of abc transporters and ecto-phosphatases for the conference of drug resistance and for the loss of drug resistance in biological systems and methods for the detection of ecto-phosphatase inhibitors |
| 09/08/2000 | CA2364169A1 Combination therapy of angiotensin converting enzyme inhibitor and epoxy-steroidal aldosterone antagonist for treatment of cardiovascular disease |
| 09/08/2000 | CA2364127A1 Composition comprising a tramadol material and a selective cox-2 inhibitor drug |
| 09/08/2000 | CA2364063A1 Use of gallic acid esters to increase bioavailability of orally administered pharmaceutical compounds |
| 09/08/2000 | CA2363983A1 Chemical method for making pyrithione particle dispersions |
| 09/08/2000 | CA2363982A1 Pharmaceutical combination of antiviral agents |
| 09/08/2000 | CA2363592A1 Oral drug delivery system |
| 09/08/2000 | CA2363169A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | CA2363077A1 Methods for targeting rna molecules |
| 09/08/2000 | CA2362985A1 Methods for identifying compounds useful for inhibiting farnesyl diphosphate synthase |
| 09/08/2000 | CA2362911A1 Heterocyclic compounds, intermediates thereof and elastase inhibitors |
| 09/08/2000 | CA2362825A1 Cdna for human methylenetetrahydrofolate reductase |
| 09/08/2000 | CA2362817A1 Novel cyclic tetrapeptide derivatives and pharmaceutical use thereof |
| 09/08/2000 | CA2362804A1 Crystal modification d of 8-cyano-1-cyclopropyl-7- (1s, 6s- 2,8- diazabicyclo- [4.3.0] nonan-8-yl) -6-fluoro -1,4-dihydro -4-oxo -3-quinoline carboxylic acid |
| 09/08/2000 | CA2362801A1 Crystal modification c of 8-cyano-1-cyclopropyl-7-(1s, 6s-2,8- diazabicyclo-[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic |
| 09/08/2000 | CA2362778A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | CA2362554A1 Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity |
| 09/08/2000 | CA2362529A1 Jak-3 inhibitors for treating allergic disorders |
| 09/08/2000 | CA2362501A1 Methods and compositions using (+) norcisapride in combination with proton pump inhibitors or h2 receptor antagonists |
| 09/08/2000 | CA2362494A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | CA2362493A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | CA2362489A1 Methods and compositions for the treatment of neuropathic pain, tinnitus, and other disorders using r(-)-ketoprofen |
| 09/08/2000 | CA2362488A1 Methods and compositions using (-) norcisapride in combination with proton pump inhibitors or h2 receptor antagonists |
| 09/08/2000 | CA2362480A1 Pharmaceutical compositions for oral administration comprising a benzamide and at least an absorption promoter |
| 09/08/2000 | CA2362364A1 Use of polycyclic thiazole systems for producing medicaments for preventing or treating obesity |
| 09/08/2000 | CA2362361A1 Bupropion metabolites and methods of their synthesis and use |
| 09/08/2000 | CA2361580A1 Thiazoloindolinone compounds |
| 09/08/2000 | CA2361164A1 Nitroxyderivatives having antiinflammatory, analgesic and antithrombotic activity |
| 09/08/2000 | CA2359754A1 Treatment or diarrhea caused by enteropathogenic escherichia coli |
| 09/08/2000 | CA2330541A1 Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| 09/07/2000 | DE19929647A1 Nifedipine pellets providing both rapid and sustained release comprise particulate core and nifedipine coating |
| 09/07/2000 | DE19910403A1 Medicaments containing hydroxy-benzo-cyclopentabenzazepine-dione derivatives, useful as cellular hyperproliferation inhibitors, especially antitumor agents |
| 09/07/2000 | DE19909979A1 Verfahren zur Herstellung von Glycokonjugaten von 20(S)-Camptothecin Process for the preparation of glycoconjugates of 20 (S) -camptothecin |
| 09/07/2000 | DE19909115A1 Verwendung von Ceramiden zur Behandlung cystischer Fibrose Use of ceramides in the treatment of cystic fibrosis |
| 09/06/2000 | EP1033375A1 Low-molecular heparin modification and remedy for skin ulcer |
| 09/06/2000 | EP1033369A1 5H-PYRANO [2,3-d:6,5-d']DIPYRIMIDINE DERIVATIVES HAVING AN ANTIBACTERIAL, ANTIVIRAL AND IMMUNO-MODULATING ACTIVITY |
| 09/06/2000 | EP1033366A2 Amide derivatives useful as Neuropeptide Y (NPY) antagonists |
| 09/06/2000 | EP1033364A1 Cyano containing oxamic acids and derivatives as thyroid receptor ligands |
| 09/06/2000 | EP1033133A1 Composition for treatment of diabetes and treatment of diabetes |
| 09/06/2000 | EP1033132A1 Rapidly soluble drug composition |
| 09/06/2000 | EP1033131A1 Composition of ingredients for a beverage having a delayed aversion effect |
| 09/06/2000 | EP1033130A1 Urokinase production inhibitors, angiogenesis inhibitors and methods of prevention or treatment with both |
| 09/06/2000 | EP1033129A1 Antimicrobials |
| 09/06/2000 | EP1033128A2 Soft gelatin capsule manufacture |
| 09/06/2000 | EP1032696A1 Vector for tissue-specific replication and gene expression |
| 09/06/2000 | EP1032676A2 $i(CHLAMYDIA TRACHOMATIS) GENOMIC SEQUENCE AND POLYPEPTIDES, FRAGMENTS THEREOF AND USES THEREOF, IN PARTICULAR FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF INFECTION |
| 09/06/2000 | EP1032667A2 A33-related antigens and their pharmacological uses |
| 09/06/2000 | EP1032662A1 Methods and compositions for immunomodulation |
| 09/06/2000 | EP1032659A1 Grafted copolymers as gene carriers |
| 09/06/2000 | EP1032591A1 NOVEL pth |
| 09/06/2000 | EP1032584A1 Novel 19-nor steroids substituted in position 11beta, preparation method and intermediates, application as medicines and pharmaceutical compositions containing them |
| 09/06/2000 | EP1032582A1 NOVEL recJ |
| 09/06/2000 | EP1032581A1 Chemical synthesis of 6-o-alkyl erythromycin a |
| 09/06/2000 | EP1032580A1 Process for n-desmethylating erythromycins and derivatives thereof |
| 09/06/2000 | EP1032579A1 Carbohydrate derivatives |
| 09/06/2000 | EP1032578A1 Novel methylenebisphosphonic acid derivatives |
| 09/06/2000 | EP1032575A1 2,3-diaryl-pyrazolo(1,5-b)pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors |
| 09/06/2000 | EP1032572A2 Pyranones, method for the production and use thereof |
| 09/06/2000 | EP1032571A1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists |
| 09/06/2000 | EP1032570A1 Isoquinoline derivatives and their therapeutical use |
| 09/06/2000 | EP1032569A1 Imidazole derivatives, preparation and therapeutic application thereof |
| 09/06/2000 | EP1032566A2 Method for the preparation of citalopram |
| 09/06/2000 | EP1032562A2 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 09/06/2000 | EP1032561A1 Substituted oximes as neurokinin antagonists |
| 09/06/2000 | EP1032560A1 Position-4 substituted 2-pyrrolidinone derivatives to reduce the level of extracellular glutamate |
| 09/06/2000 | EP1032559A1 Aminoalkylphenol derivatives and related compounds |
| 09/06/2000 | EP1032556A1 Pharmaceutically active compounds and methods of use |
| 09/06/2000 | EP1032555A1 Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
| 09/06/2000 | EP1032424A1 Combination of an aldose reductase inhibitor and a glycogen phosphorylase inhibitor |
| 09/06/2000 | EP1032423A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof |
| 09/06/2000 | EP1032415A2 Composition for the treatment of allergic conditions having cysteine and serine proteinase inhibitory activity |
| 09/06/2000 | EP1032414A1 Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders |
| 09/06/2000 | EP1032410A1 Activating c1?- secretion |
| 09/06/2000 | EP1032409A1 Herbal extract composition and method with immune-boosting capability |
| 09/06/2000 | EP1032406A1 Reducing blood cholesterol by in vivo precipitation of bile constituents with group ii or -iii metal substances |
| 09/06/2000 | EP1032405A1 Antimutagenic compositions for treatment and prevention of photodamage to skin |
| 09/06/2000 | EP1032404A1 Use of sulfated oligosaccharides in lowering blood triglyceride levels |
| 09/06/2000 | EP1032403A1 Nutritional supplement for cerebral metabolic insufficiencies |
| 09/06/2000 | EP1032402A1 Citicoline to treat motor neuron diseases and demyelinating diseases |
| 09/06/2000 | EP1032401A2 Method for inhibiting cytokine production by cells |
| 09/06/2000 | EP1032400A1 Prevention of precipitated acute urinary retention |
| 09/06/2000 | EP1032399A1 Progestin therapy with controlled bleeding |
| 09/06/2000 | EP1032398A1 Methods for treating postmenopausal women using ultra-low doses of estrogen |
| 09/06/2000 | EP1032397A1 Testosterone inhibitors and use for the protection of neurons |
| 09/06/2000 | EP1032396A1 New composition of matter |
| 09/06/2000 | EP1032395A1 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 09/06/2000 | EP1032394A1 Use of substituted 11-phenyl-dibenzazepine compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scour |